For patients with agitation associated with dementia due to Alzheimer's disease,

When redirection isn't enough, REXULTI® (brexpiprazole) is proven to reduce the frequency of agitation symptoms

Limitations of Use: REXULTI is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease.

desktop-home
mobile-home
Actor portrayals.
Explore Pivotal Study Data
/content/rexulti/hcp/websites/aad/efficacy
Review Extension Study Data
/content/rexulti/hcp/websites/aad/safety#exploratoryanalysis
See safety profile
/content/rexulti/hcp/websites/aad/safety
View dosing and titration
/content/rexulti/hcp/websites/aad/dosing
Please see FULL PRESCRIBING INFORMATION,
including BOXED WARNING.